Neuroscience News and Research

RSS

Sangamo BioSciences fourth quarter revenues increase to $8.9 million

Sangamo BioSciences, Inc. today reported fourth quarter and full year 2012 financial results and accomplishments.

7 Feb 2013

U.S. adults with diabetes report increased satisfaction with Roche's ACCU-CHEK products

Adults living with diabetes in the United States reported highest satisfaction using Roche Diabetes Care's ACCU-CHEK products compared with other blood glucose meter manufacturers, according to the inaugural J.D. Power and Associates 2012 Blood Glucose Meter Satisfaction Study.

6 Feb 2013

Teva initiates enrollment in AZILECT Phase IV clinical study for PD-MCI

Teva Pharmaceutical Industries Ltd. announced today enrollment of the first patient in the MODERATO study - a Phase IV clinical study designed to evaluate the effect of AZILECT (rasagiline tablets) on cognitive function in adults with mild cognitive impairment (MCI) in Parkinson's disease (PD-MCI).

6 Feb 2013

DCC receptor plays key role in regulating brain plasticity

Our ability to learn and form new memories is fully dependent on the brain's ability to be plastic - that is to change and adapt according to new experiences and environments. A new study from the Montreal Neurological Institute - The Neuro, McGill University, reveals that DCC, the receptor for a crucial protein in the nervous system known as netrin, plays a key role in regulating the plasticity of nerve cell connections in the brain.

5 Feb 2013

Presenilin-1 gene plays central role in development of neuronal histamine system

Researchers at University of Helsinki, Finland, have shown in a study conducted on zebrafish, that the presenilin-1 (psen1) gene associated with Alzheimer's disease functions as a central regulator for the development of the histamine system. Histamine system is also altered in patients suffering from Alzheimer's disease.

5 Feb 2013

An Introduction to the LV200 Bioluminescence Microscope

News-Medical speaks to Robert Schmalzigaug to explore the field of bioluminescence imaging and the applications of the LV200 microscope.

From Evident Corporation - Life Sciences 5 Feb 2013

Nitric oxide shuts down brain's repair mechanisms

Nitric oxide, a gaseous molecule produced in the brain, can damage neurons. When the brain produces too much nitric oxide, it contributes to the severity and progression of stroke and neurodegenerative diseases such as Alzheimer's. Researchers at Sanford-Burnham Medical Research Institute recently discovered that nitric oxide not only damages neurons, it also shuts down the brain's repair mechanisms.

5 Feb 2013

Amygdala not the only gatekeeper of fear in human mind

When doctors at the University of Iowa prepared a patient to inhale a panic-inducing dose of carbon dioxide, she was fearless. But within seconds of breathing in the mixture, she cried for help, overwhelmed by the sensation that she was suffocating.

5 Feb 2013

Scientists identify two areas of brain responsible for perception of orientation and shape

A new study led by scientists at the Universities of York and Bradford has identified the two areas of the brain responsible for our perception of orientation and shape.

4 Feb 2013

Identification of progenitors may help treat clinical taste dysfunction

Scientists at the Monell Center have identified the location and certain genetic characteristics of taste stem cells on the tongue. The findings will facilitate techniques to grow and manipulate new functional taste cells for both clinical and research purposes.

4 Feb 2013

Two new methods could accelerate development of improved antisense drugs

Powerful antisense drugs that target disease-associated genes to block their expression can be used to treat a broad range of diseases. Though antisense therapy has been proven effective, challenges remain in ensuring that the drugs reach their intended targets.

2 Feb 2013

Modafinil may help some people to reduce drinking by improving their impulse control

Poor impulse control contributes to one's inability to control the consumption of rewarding substances, like food, alcohol, and other drugs. This can lead to the development of addiction. FDA-approved medications for alcoholism, like naltrexone (Revia) and disulfiram (Antabuse), are thought to reduce alcohol consumption by curbing cravings and creating unpleasant reactions to alcohol, effects which reduce the desire to drink alcohol.

2 Feb 2013

Book reviews psilocybin's potential in alleviating psychological distress in cancer patients

Improvements in the diagnosis and treatment of cancers in recent years have led to a marked increase in patients' physical survival rates. While doctors can treat the physical disease, what is not well understood is how best to address the psychological needs of patients with cancer.

1 Feb 2013

Study supports hypothesis that disulfiram reduces drug consumption by blocking DβH

Disulfiram was the first medication approved for the treatment of alcoholism over 50 years ago. It works, at least in part, by preventing the metabolism of an alcohol by-product, acetaldehyde. High levels of acetaldehyde in the body quickly cause unpleasant symptoms, including nausea, vomiting, headache, and accelerated heart rate. Thus, disulfiram provides a very strong incentive to avoid drinking.

1 Feb 2013

FET programme picks Graphene and HumanBrain among six visions for frontier research

Europe is set to embark on two bold, visionary projects. The projects aim to invest up to one billion euroover ten years to fuel revolutionary discoveries. The Future and Emerging Technologies Flagship (FET) programme picked two among six visions for frontier research.

31 Jan 2013

RBC Life Sciences receives U.S. patent for Neurobright supplement

RBC Life Sciences, Inc., has been granted US Patent 8357422, which protects its unique dietary supplement formulation that nutritionally supports cognitive function, learning and remembering. The Company markets this supplement under the name "Neurobright."

31 Jan 2013

Erbin protein critical to brain excitement

Scientists have found an early step in how the brain's inhibitory cells get excited. A natural balance of excitement and inhibition keeps the brain from firing electrical impulses randomly and excessively, resulting in problems such as schizophrenia and seizures. However excitement is required to put on the brakes.

31 Jan 2013

Klotho protein plays important role in the health of myelin

Researchers at Boston University School of Medicine (BUSM) led by Carmela Abraham, PhD, professor of biochemistry, along with Cidi Chen, PhD, and other collaborators, report that the protein Klotho plays an important role in the health of myelin, the insulating material allowing for the rapid communication between nerve cells.

31 Jan 2013

Study illuminates the response of dopaminergic neurons to changes in temperature

While the wooly musk ox may like it cold, fruit flies definitely do not. They like it hot, or at least warm. In fact, their preferred optimum temperature is very similar to that of humans-76 degrees F.

31 Jan 2013

MiR-182 deeply involved in memory formation within the amygdala brain structure

It takes a lot to make a memory. New proteins have to be synthesized, neuron structures altered. While some of these memory-building mechanisms are known, many are not. Some recent studies have indicated that a unique group of molecules called microRNAs, known to control production of proteins in cells, may play a far more important role in memory formation than previously thought.

30 Jan 2013

Neuroscience News and Research

Sangamo BioSciences fourth quarter revenues increase to $8.9 million

U.S. adults with diabetes report increased satisfaction with Roche's ACCU-CHEK products

Teva initiates enrollment in AZILECT Phase IV clinical study for PD-MCI

DCC receptor plays key role in regulating brain plasticity

Presenilin-1 gene plays central role in development of neuronal histamine system

An Introduction to the LV200 Bioluminescence Microscope

Nitric oxide shuts down brain's repair mechanisms

Amygdala not the only gatekeeper of fear in human mind

Scientists identify two areas of brain responsible for perception of orientation and shape

Identification of progenitors may help treat clinical taste dysfunction

Two new methods could accelerate development of improved antisense drugs

Modafinil may help some people to reduce drinking by improving their impulse control

Book reviews psilocybin's potential in alleviating psychological distress in cancer patients

Study supports hypothesis that disulfiram reduces drug consumption by blocking DβH

FET programme picks Graphene and HumanBrain among six visions for frontier research

RBC Life Sciences receives U.S. patent for Neurobright supplement

Erbin protein critical to brain excitement

Klotho protein plays important role in the health of myelin

Study illuminates the response of dopaminergic neurons to changes in temperature

MiR-182 deeply involved in memory formation within the amygdala brain structure

Event guide: 8th Neuroimmunology Drug Development Summit 2026 eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News